undefined
EUTM file information

019178680

Biobrew by ABInBev


April 24, 2025

Trademark Summary

The trademark application Biobrew by ABInBev was filed by Anheuser-Busch InBev S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). Application filed.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Proteins for use in fermentation technology
    2. Proteins for use in recombinant DNA technology (other than for medical use)
    3. Proteins, fats, carbohydrates, vitamins, minerals, fibers for use in the food industry
    4. Pectin, lecithin, enzymes and chemical preservatives, amino acids all for use in the food industry
    5. Chemical ingredients for use in the manufacture of cosmetics and pharmaceuticals and nutraceuticals, namely chemicals, vitamins, minerals, fats, fibers, proteins, carbohydrates, amino acids
    6. Proteins for food, including diary and egg proteins
    7. Heme
    8. Plant extracts for industrial purpose
    9. Collagen for industrial purposes.
  • The mark was filed in class 5 with Dietary supplements, intended to supplement a normal diet or to have health benefits.
  • The mark was filed in class 29 with Oils, fats including vegetable and algae fats and meat, fish, poultry and game, meat extracts, meat substitutes, eggs, milk and milk products, dairy and egg proteins..
  • The mark was filed in class 40 with The custom manufacturing of proteins, carbohydrates, fibers, fats, vitamins, minerals to the order and specification of others, fermentation services.
  • The mark was filed in class 42 with following description of goods:
    1. Biotechnology research
    2. Consultancy relating to biotechnology
    3. Providing information relating to scientific research in the field of biochemistry and biotechnology
    4. Research and development in the field of biotechnology
    5. Hosting of e-commerce platforms on the internet.